Knowing a newborn's genetic predisposition to diseases like diabetes is only the first step. We provide actionable medical foresight and personalized precautionary roadmaps to safeguard your child's future.
Following the initial genome sequence, we generate highly targeted lifestyle, dietary, and medical intervention roadmaps designed specifically around the newborn's DNA profile.
Deep dive into the specific genetic anomalies identified during initial screening.
Translating complex genetic markers (e.g. for Thalassemia) into clear precautionary steps.
Preparing medical systems for early, targeted therapeutic intervention if needed.
Each Novo Aetas program is designed around traceable data handling, reviewable outputs, and clear next steps for the teams responsible for acting on the results.
A structured intake process to confirm sample type, goals, constraints and decision criteria before analysis begins.
Access-controlled workflows for sensitive genomic, molecular, agricultural and partner operating data.
Plain-language summaries, technical detail and practical recommendations tailored to the project context.
A final walkthrough with stakeholders so findings are understood before pilots, care planning or deployment.
Discover the power of Novo Aetas biotech infrastructure today. Let's build the future together.